Cardiovascular morbidity and mortality after treatment for ductal carcinoma in situ of the breast

Journal of the National Cancer Institute

Volumn 106, Issue 8, 2014, Pages

  Boekel, Naomi B ^a   Schaapveld, Michael ^a   Gietema, Jourik A ^b   Rutgers, Emiel J T ^a   Versteegh, Michel I M ^c   Visser, Otto ^d   Aleman, Berthe M P ^a   Van Leeuwen, Flora E ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Netherlands Comprehensive Cancer Organisation The Netherlands   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVOR; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; DYING; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HOSPITAL ADMISSION; HUMAN; INTRADUCTAL CARCINOMA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MASTECTOMY; MIDDLE AGED; NETHERLANDS; PERICARDITIS; POPULATION RESEARCH; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIATION INJURY; STANDARDIZED MORTALITY RATIO; VALVULAR HEART DISEASE; WIDE EXCISION; ADJUVANT THERAPY; BREAST TUMOR; COMPARATIVE STUDY; EPIDEMIOLOGY; MEDICAL RECORD; METHODOLOGY; MORBIDITY; MORTALITY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; REGISTER; RISK ASSESSMENT; TIME;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARDIOVASCULAR DISEASES; CONFOUNDING FACTORS (EPIDEMIOLOGY); DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY; MEDICAL RECORD LINKAGE; MIDDLE AGED; MORBIDITY; NETHERLANDS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; REGISTRIES; RISK ASSESSMENT; TIME FACTORS;

EID: 84906998287     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dju156     Document Type: Article

References (26)

1. Li CI, Daling JR, Malone KE. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001. Cancer Epidemiol Biomarkers Prev. 2005;14(4):1008-1011.
2. Puig-Vives M, Pollan M, Rue M, et al. Rapid increase in incidence of breast ductal carcinoma in situ in Girona, Spain 1983-2007. Breast. 2012;21(5):646-651.
3. Sorum R, Hofvind S, Skaane P, et al. Trends in incidence of ductal carcinoma in situ: the effect of a population-based screening programme. Breast. 2010;19(6):499-505.
4. van Steenbergen LN, Voogd AC, Roukema JA, et al. Screening caused rising incidence rates of ductal carcinoma in situ of the breast. Breast Cancer Res Treat. 2009;115(1):181-183.
5. Virnig BA, Shamliyan T, Tuttle TM, et al. Diagnosis and management of ductal carcinoma in situ (DCIS). Evid Rep Technol Assess. 2009;(185):1-549.
6. Aleman BM, AW vdB-D, De Bruin ML, et al. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood. 2007;109(5):1878-1886.
7. Hancock SL, Hoppe RT, Horning SJ, et al. Intercurrent death after Hodgkin disease therapy in radiotherapy and adjuvant MOPP trials. Ann Intern Med. 1988;109(3):183-189.
8. Swerdlow AJ, Higgins CD, Smith P, et al. Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. J Natl Cancer Inst. 2007;99(3):206-214.
9. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366(9503):2087-2106.
10. Darby SC, McGale P, Taylor CW, et al. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 2005;6(8):557-565.
11. Preston DL, Shimizu Y, Pierce DA, et al. Studies of mortality of atomic bomb survivors. Report 13: solid cancer and noncancer disease mortality: 1950-1997. Radiat Res. 2003;160(4):381-407.
12. Shimizu Y, Kodama K, Nishi N, et al. Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003. BMJ. 2010;340:b5349.
13. Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368(11):987-998.
14. Taylor CW, Bronnum D, Darby SC, et al. Cardiac dose estimates from Danish and Swedish breast cancer radiotherapy during 1977-2001. Radiother Oncol. 2011;100(2):176-183.
15. Correa C, McGale P, Taylor C, et al. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr. 2010;2010(41):162-177.
16. Ernster VL, Barclay J, Kerlikowske K, et al. Mortality among women with ductal carcinoma in situ of the breast in the population-based Surveillance, Epidemiology and End Results program. Arch Intern Med. 2000;160(7):953-958.
17. Park CK, Li X, Starr J, et al. Cardiac morbidity and mortality in women with ductal carcinoma in situ of the breast treated with breast conservation therapy. Breast J. 2011;17(5):470-476.
18. van der Sanden GA, Coebergh JW, Schouten LJ, et al. Cancer incidence in the Netherlands in 1989 and 1990: first results of the nationwide Netherlands cancer registry. Coordinating Committee for Regional Cancer Registries. Eur J Cancer. 1995;31A(11):1822-1829.
19. de Heer F, Groenwold RHH, ter Burg WJ, et al. Nederlandse hartchirurgie over de periode 1995-2009 en de prognose tot 2020. In: Vaartjes I, van Dis I, Visseren FLJ, et al., eds. Hart-en vaatziekten in Nederland 2011, cijfers over leefstijl-en risicofactoren, ziekte en sterfte. Den Haag: Hartstichting; 2011:31-41.
20. World Health Organization. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death, Volume Geneva: World Health Organization; 1977.
21. Fine JPG, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496-509
22. Cuzick J, Stewart H, Rutqvist L, et al. Cause-specific mortality in longterm survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol. 1994;12(3):447-453.
23. Giordano SH, Kuo YF, Freeman JL, et al. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst. 2005;97(6):419-424.
24. Hooning MJ, Aleman BM, van Rosmalen AJ, et al. Cause-specific mortality in long-term survivors of breast cancer: a 25-year follow-up study. Int J Radiat Oncol Biol Phys. 2006;64(4):1081-1091.
25. Borger JH, Hooning MJ, Boersma LJ, et al. Cardiotoxic effects of tangential breast irradiation in early breast cancer patients: the role of irradiated heart volume. Int J Radiat Oncol Biol Phys. 2007;69(4):1131-1138.
26. Hooning MJ, Botma A, Aleman BM, et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst. 2007;99(5):365-375.